𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)

✍ Scribed by Angela Philippen; Susanne Diener; Thorsten Zenz; Hartmut Döhner; Stephan Stilgenbauer; Daniel Mertens

Book ID
108676835
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
162 KB
Volume
150
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive leukapheresis in the managemen
Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphoma
✍ Dr. I. A. Cooper; J. C. Ding; P. B. Adams; M. A. Quinn; M. Brettell 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

## Abstract The role of leukapheresis was explored in the management of anaemia and thrombocytopenia complicating the accumulation of lymphoid cells in patients with chronic lymphocytic leukaemia and lymphoma. The aim of this study was to determine the efficiency of this procedure in correcting the

IgVH gene mutation status and genomic im
IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL)
✍ Zsófia Balogh; Lilla Reiniger; Linda Deák; Csaba Bödör; Judit Csomor; Ágota Szep 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Chronic lymphocytic leukaemia (CLL) with increased prolymphocytes (CLL/PL) has been defined by the World Health Organization (WHO) classification and considered as a progressive and clinically aggressive variant of CLL. To further characterize the biological features of this disease, we performed Ig